Last reviewed · How we verify
NCT05208788
Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx)
trial testing Biomarker test in Renal Transplantation in 186 participants. Completed in 1 February 2023.
1 February 2023
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 186 |
| Start date | 1 June 2021 |
| Primary completion | 1 February 2023 |
| Estimated completion | 1 February 2023 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Biomarker test
Conditions studied
- Renal Transplantation — all drugs for Renal Transplantation →
- Chronic Kidney Insufficiency — all drugs for Chronic Kidney Insufficiency →
- Healthy Controls — all drugs for Healthy Controls →
Sponsor
University Hospital Tuebingen
Who can join
Adults 0 to 17, any sex, with Renal Transplantation or Chronic Kidney Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to test and validate the panel of study urinary biomarker to assess whether (1) reference values differ between paediatric renal transplant patients, patients with chronic kidney disease stage IV and V (CKD IV-V) and children without any disease, (2) characteristic changes in concentration profile may be observed after event-specific injury, (3) differences between paediatric renal transplant patients with AR and other causes of AKI can be detected, and (4) stratification of renal transplant patients to different histological types of AR is possible.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials.
Asaf S, Maqsood F, Jalil J, Sarfraz Z, et al · · 2023 · cited 38× · PMID 36529828 · DOI 10.1007/s12026-022-09352-2
Verify or expand the search:
- PubMed search for NCT05208788
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biomarker test
Trials testing the same drug.
- NCT03789565 — Hepcidin Levels in Periodontal Health and Disease · completed
Other recruiting trials for Renal Transplantation
Currently open trials in the same condition.
- NCT07294183 — The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation · NA · recruiting
- NCT07045467 — Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study · Phase 1 · recruiting
- NCT06406179 — Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients" · NA · recruiting
- NCT06026592 — Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients · recruiting
- NCT03266393 — Envarsus XR® in Adolescent Renal Transplant Recipients · Phase 4 · active not recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05208788 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05208788.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing